Internal Medicine, Gastroenterology · Oxford, MS
NPI
1225046543
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1208 Office Park Dr
Oxford, MS, 38655
Phone (662) 234-9888
Groups this clinician bills Medicare through
Medicare paid, 2024
$302K
10,152 services
Medicare patients, 2024
797
Average age 72
Drug cost, 2024
$722K
6,221 prescriptions
Company payments, 2025
$2,363
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen T Threadgill was code 99214 (office e&m - established), 243 times for 164 patients. In total Stephen T Threadgill billed 10,152 services in 52 codes, and Medicare paid $302K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 243 | 164 | $92.09 | $22K |
| 45384 Colonoscopy - Lesion Removal | Facility | 161 | 160 | $127.09 | $20K |
| 45385 Colonoscopy - Lesion Removal | Facility | 142 | 140 | $196.16 | $28K |
| 99213 Office E&M - Established | Office | 133 | 110 | $63.25 | $8,412 |
| 43450 Digestive/Gastrointestinal | Facility | 122 | 121 | $30.85 | $3,764 |
| 43235 Upper GI Endoscopy | Facility | 94 | 94 | $81.30 | $7,642 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 82 | 82 | $177.25 | $15K |
| 43239 Upper GI Endoscopy | Facility | 79 | 78 | $74.55 | $5,889 |
| 99204 Office E&M - New | Office | 62 | 62 | $115.29 | $7,148 |
| 45381 Lower GI Endoscopy - Other | Facility | 49 | 48 | $14.23 | $697 |
| 45380 Lower GI Endoscopy - Other | Facility | 42 | 42 | $86.15 | $3,618 |
| 43248 Upper GI Endoscopy | Facility | 40 | 39 | $109.89 | $4,395 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 39 | 39 | $175.23 | $6,834 |
| 91010 Test - Miscellaneous | Facility | 37 | 37 | $49.96 | $1,849 |
| 99203 Office E&M - New | Office | 35 | 35 | $76.93 | $2,693 |
By year: 2022 $285K for 7,501 services; 2023 $256K for 7,436 services; 2024 $302K for 10,152 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephen T Threadgill prescribed most often to Medicare patients was Pantoprazole Sodium, with 1,601 prescriptions and refills. In total Stephen T Threadgill wrote 6,221 Medicare prescriptions that cost $722K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 1,601 | 2,813 | 377 | $21K |
| Famotidine Generic | 935 | 1,493 | 220 | $17K |
| Omeprazole Generic | 645 | 1,199 | 181 | $6,152 |
| Ondansetron Odt Ondansetron | 246 | 261 | 100 | $4,166 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 246 | 257 | 242 | $16K |
| Misoprostol Generic | 229 | 270 | 63 | $18K |
| Dicyclomine Hcl Generic | 192 | 245 | 44 | $2,555 |
| Metronidazole Generic | 165 | 174 | 80 | $2,556 |
| Promethazine Hcl Generic | 154 | 155 | 24 | $4,121 |
| Linzess Linaclotide | 104 | 159 | 40 | $78K |
| Ondansetron Hcl Generic | 98 | 105 | 17 | $1,697 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 97 | 102 | 44 | $1,502 |
| Colestipol Hcl Generic | 85 | 93 | 27 | $6,746 |
| Esomeprazole Magnesium Generic | 82 | 130 | 14 | $2,175 |
| Ciprofloxacin Hcl Generic | 75 | 75 | 34 | $319 |
Brand drugs: 614 claims; generic drugs: 5,607 claims; opioid claims: 87.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen T Threadgill $2,363 ($2,363 in general payments such as food, travel and fees) from 21 companies. The largest payer was Lilly USA, LLC with $353.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 9 | $353 |
| Enterra Medical, Inc. | 3 | $352 |
| Abbvie Inc. ABBV | 24 | $315 |
| Janssen Biotech, Inc. JNJ | 11 | $276 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 10 | $184 |
| Pfizer Inc. PFE | 6 | $182 |
| W. L. Gore & Associates, Inc. | 1 | $128 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $108 |
| Genzyme Corporation SNY | 4 | $87.44 |
| Ardelyx, Inc. ARDX | 3 | $75.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.